10.07.26 -- Engineering Better ADCs, Part 1: MoA, Conjugation Chemistry, And More

Improve UF/DF repeatability by defining clear concentration and diafiltration endpoints, matching them with appropriate measurements, and applying real-time in-line analytics to reduce variability.

See how membrane and multi-column chromatography compare with traditional Protein A capture in productivity, cost, scalability, and performance, including results from pilot-scale membrane testing.

Go beyond the ELISA by leveraging mass spectrometry. Identify specific high-risk proteins and ensure your purification process meets the highest standards of safety.

Protein A chromatography intensification can increase productivity, but it may also affect process robustness. Explore key tradeoffs, operational challenges, and practical considerations.

Discover end-to-end strategies for therapeutic peptide characterization, including purity, structure, stability, and more, alongside expert services designed to strengthen workflow consistency.

Uncover how integrated approaches and process simplification can reduce bottlenecks, improve consistency, and support high-quality manufacturing outcomes across increasingly challenging pipelines.

Personalized cancer vaccines are advancing quickly, but effective delivery remains a major hurdle. Learn how mRNA and lipid nanoparticle design influence targeting, endosomal escape, and repeat dosing.

Drug formulations demand more than single‑point viscosity data. Gain insight into how rheology reveals stability, flow, and structural behavior across suspensions, topicals, and injectables.

Automated fill-finish systems protect sensitive cell therapies using low-shear handling to maintain dose uniformity, cell viability, and process consistency across every batch.

Pharma 4.0™ leverages IoT, AI, and automation to enhance drug quality. Evaluate your fill-finish line readiness by considering five key questions on modularity and high-risk process automation.